Search results :

Nevirapine

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: J05AG01

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Dermatitis Rash postmarketing — 4% - 24% 1.5% - 14.9% x x x x x x x x x x x x x x x x
Rash Rash postmarketing — 4% - 24% 1.5% - 14.9% x x x x x x x x x x x x x x x x
Liver function test abnormal Liver function test abnormal common, 1.2% - 6.7% 0.9% - 1.5% x x x x x
Alanine aminotransferase increased Alanine aminotransferase increased common x x x x
Headache Headache common, 0.7% - 4% 0.4% - 1% x x x x x x x x x x x x x x x x
Abdominal pain Abdominal pain common, 0.1% - 3% 0% - 1% x x x x x x x x x x x x x x x x
Gastrointestinal pain Abdominal pain common, 0.1% - 3% 0% - 1% x x x x x x x x x x x x x x x x
Diarrhoea Diarrhoea common, 0.2% - 4% 0.5% - 1% x x x x x x x x x x x x x x x x
Nausea Nausea common, 0.5% - 9% 1% - 4% x x x x x x x x x x x x x x x x
Hepatotoxicity Hepatotoxicity common, 2% - 2.4% x x x x x x x x x x
Myalgia Myalgia postmarketing — 0.2% - 1.2% 0% - 2% x x x x x x x x x x x x x x
Musculoskeletal discomfort Myalgia postmarketing — 0.2% - 1.2% 0% - 2% x x x x x x x x x x x x x x
Arthralgia postmarketing — 2% x x x x x x x x x x x x x x x x
Drug eruption Drug eruption uncommon x x
Blood pressure increased Blood pressure increased uncommon x x x x
Blood phosphorus decreased Blood phosphorus decreased uncommon x x x x
Agranulocytosis Agranulocytosis postmarketing — 0.4% - 3.3% 0% - 3% x x x x x x x x x x x x x x x x
Asthenia Fatigue postmarketing — 0.2% - 5% 0.3% - 4% x x x x x x x x x x x x x x x x
Fatigue Fatigue postmarketing — 0.2% - 5% 0.3% - 4% x x x x x x x x x x x x x x x x
Toxic epidermal necrolysis Toxic epidermal necrolysis postmarketing, uncommon x x x x x x x x x x x x x x x x
Erythema multiforme Stevens-Johnson syndrome postmarketing — 0.3% x x x x x x x x x x x x x x x x
Erythema multiforme x
Stevens-Johnson syndrome Stevens-Johnson syndrome postmarketing — 0.3% x x x x x x x x x x x x x x x x
Anaphylactic shock Anaphylactic shock postmarketing — common x x x x x x x x x x x x x x x x
Anaemia Anaemia postmarketing — 7% - 7.3% x x x x x x x x x x x x x x x x
Angioedema Angioedema postmarketing — common x x x x x x x x x x x x x x x x
Arthralgia Arthralgia postmarketing — 2% x x x x x x x x x x x x x x x x
Blister Blister postmarketing x x x x x x x x x x x x x
Dermatitis bullous Blister postmarketing x x x x x x x x x x x x x
Bullous eruption postmarketing x x x x x x x x x x x x x
Conjunctivitis Conjunctivitis postmarketing x x x x x x x x x x x x x
Oedema Oedema postmarketing x
Eosinophilia Eosinophilia postmarketing, uncommon x x x x x x x x x x x x x x x x
Body temperature increased Body temperature increased postmarketing — 1% - 2% x x x x x x x x x x x x x x x x
Hepatitis Hepatitis postmarketing — 1.2% - 4% x x x x x x x x x x x x x x x x
Hypersensitivity Hypersensitivity postmarketing, common x x x x x x x x x x x x x x x x
Jaundice Jaundice postmarketing, uncommon x x x x x x x x x x x x x x x x
Neutropenia Neutropenia postmarketing, 8.9% - 9% x x x x x x x x x x x x x x
Paraesthesia Paraesthesia postmarketing x x x x x x x x x x x x
Paraesthesia skin postmarketing x
Rhabdomyolysis Rhabdomyolysis postmarketing x x x x x x x x x
Mouth ulceration Ulcerative stomatitis postmarketing x x x x x x x x x x x x x
Urticaria Urticaria postmarketing, uncommon x x x x x x x x x x x x x x x x
Vomiting Vomiting postmarketing, common x x x x x x x x x x x x x x x x
Hepatic failure Hepatic failure postmarketing, rare x x x x x x x x x x x x x x x x
Oral disorder Oral lesion postmarketing x x x x x x x x x x x x x
Hepatitis cholestatic Hepatitis cholestatic postmarketing x x x x x x x x x x x x x
Hepatic necrosis Hepatic necrosis postmarketing x x x x x x x x x x x x x
Malaise Malaise postmarketing x x x x x x x x x x x x x
Discomfort Malaise postmarketing x x x x x x x x x x x x x
Feeling abnormal Malaise postmarketing x x x x x x x x x x x x x
Ill-defined disorder Malaise postmarketing x x x x x x x x x x x x x
Pain Ache postmarketing x x x x x x x x x x x x x
Hepatitis fulminant Hepatitis fulminant rare x x x x x
Lymphadenopathy Lymphadenopathy postmarketing x x x x x x x x x x x x x x x x
Face oedema Face oedema postmarketing x x x x x x x x x x x x
Drug reaction with eosinophilia and systemic symptoms Hypersensitive syndrome postmarketing x x x x x x x x x x x x x x
Drug interaction Drug interaction postmarketing x x x x x x x x x
Somnolence Somnolence postmarketing x x x x x x x x x x x x x
Congenital anomaly Congenital anomaly x
Developmental delay Congenital anomaly x
Decreased appetite Anorexia x x
Autoimmune disorder Autoimmune disorder x x
Bone disorder Bone disorder x
Connective tissue disorder Connective tissue disorder x x x
Dermatitis exfoliative Dermatitis exfoliative x
Erythema nodosum Erythema nodosum x
Gastrointestinal disorder Gastrointestinal disorder x x x x
Basedow's disease Basedow's disease x x
Hepatitis toxic Hepatitis toxic x
Hypercholesterolaemia Hypercholesterolaemia x x
Hyperglycaemia Hyperglycaemia x x
Hypertriglyceridaemia Hypertriglyceridaemia x x
Blood triglycerides increased Hypertriglyceridaemia x x
Breast enlargement Hypertrophy of breast x x
Immune system disorder Immune system disorder x x x x
Inflammation Inflammation x x
Insulin resistance Insulin resistance x x
Lipodystrophy acquired Lipodystrophy x x
Liver disorder Liver disorder x
Hepatocellular injury Liver disorder x
Foetor hepaticus Liver disorder x
Necrosis Necrosis x
Nervous system disorder Nervous system disorder x x x x
Opportunistic infection Opportunistic infection x x
Pancreatitis Pancreatitis x x x
Neuropathy peripheral Neuropathy peripheral x x x
Pruritus Pruritus x x x x x x x x x x x x x x x x
Renal failure Renal failure x x
Thrombocytopenia Thrombocytopenia x x x x x x x x x x x x
Ulcer Ulcer x
Erythema Erythema x
Gamma-glutamyltransferase increased Gamma-glutamyltransferase increased x x x x
Aspartate aminotransferase increased Aspartate aminotransferase increased x x x x
Liver injury Liver injury x
Traumatic liver injury Liver injury x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x x x x
Rash erythematous Rash erythematous x x x x x x x x x x x x x x x x
Hepatic enzyme increased Hepatic enzyme increased x x x x
Skin exfoliation Skin exfoliation x
Vertical infection transmission Vertical infection transmission x
Hepatobiliary disease Hepatobiliary disease x x x x
Hepatitis acute Hepatitis acute x
Rash maculo-papular Rash maculo-papular x x
Transaminases increased Transaminases increased x x x x
Lipohypertrophy Buffalo hump x x
Chronic hepatitis B Chronic hepatitis B x
Surgery Surgical intervention x x
Hyperlactacidaemia Hyperlactacidaemia x x
Fat redistribution Fat redistribution x x x
Rash papular Rash papular x
Hypertransaminasaemia Hypertransaminasaemia x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

NEVIRAPINE

Side effects:41
Source:FDA Structured Product Label

NEVIRAPINE / VIRAMUNE

Side effects:42
Source:FDA

NEVIRAPINE / VIRAMUNE

Side effects:41
Source:FDA

NEVIRAPINE / VIRAMUNE

Side effects:42
Source:FDA

NEVIRAPINE

Side effects:43
Source:FDA Structured Product Label

NEVIRAPINE

Side effects:43
Source:FDA Structured Product Label

NEVIRAPINE

Side effects:43
Source:FDA Structured Product Label

nevirapine

Side effects:43
Source:FDA Structured Product Label

NEVIRAPINE

Side effects:43
Source:FDA Structured Product Label

NEVIRAPINE / VIRAMUNE

Side effects:43
Source:FDA

NEVIRAPINE

Side effects:47
Source:FDA Structured Product Label

NEVIRAPINE / VIRAMUNE

Side effects:54
Source:Health Canada

Nevirapine / Nevirapine

Side effects:58
Source:medicines.org.au

nevirapine / nevirapine

Side effects:60
Source:EMA

nevirapine / nevirapine

Side effects:61
Source:EMA

Color scheme:

standardalternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label